Literature DB >> 29552095

Clostridium difficile multidisciplinary team root cause analysis: impact on clinical care and circumvention of financial penalties posed by clinical commissioning groups, but at what cost?

Kordo Saeed1,2, Christina Petridou3, Hazel Gray4, Matthew Dryden1,2, Karen Davis-Blues4, Sheryl Lucero4, Natalie Parker5, Taryn Keyser5, Tanya Matthews4, Nick Cortes1,2, Stephen Kidd1, Claire Thomas1, Heather Peacock4, Joanna Hornzee4, Bruce Wake4.   

Abstract

BACKGROUND: In Hampshire Hospitals NHS Foundation Trust, in addition to an on-the-spot investigation into hospital-onset Clostridium difficile infection (CDI) by the infection prevention team, a multidisciplinary team root cause analysis (MDT-RCA) forum has been developed. The MDT-RCA aims to deliver a more thorough investigation into individual cases and the recommendation of cases to the clinical commissioning groups (CCG) appeals panel against potential financial penalties (£10,000 per breached case). We mainly aimed to investigate the financial impact of MDT-RCAs to the Trust.
METHODOLOGY: Over two years, 84 cases of hospital-onset CDI cases were reviewed by the MDT-RCA forum.
RESULTS: Among this cohort, no additional learning outcomes were identified by the MDT-RCAs over those that were found by on-the-spot investigations. In total, 543 staff members attended the MDT-RCAs at a potential cost to the Trust of £23,795.74-£51,670.10. The Trust appealed against financial penalties for 27 cases and 14 were successful, i.e. £140,000 would have been avoided had targets been breached by 14 cases. However, targets were only breached by two cases, meaning only £20,000 in fines was avoided. Deducting this from the total costs of the MDT-RCA meant the Trust lost £3,795.74-£31,670.10.
CONCLUSION: Over the two years reviewed, the MDT-RCA proved to be costly to the Trust, with no additional learning or quality improvement measures identified.

Entities:  

Keywords:  Clostridium difficile; Clostridium difficile infection; clinical commissioning group; root cause analysis

Year:  2017        PMID: 29552095      PMCID: PMC5846979          DOI: 10.1177/1757177417726155

Source DB:  PubMed          Journal:  J Infect Prev        ISSN: 1757-1782


  10 in total

1.  Cost-analysis of an intensive care unit closure due to an imipenem-resistant oxa-23 Acinetobacter baumannii outbreak.

Authors:  R Garlantézec; C Bourigault; J M Boles; G Prat; R Baron; J M Tonnelier; M Cosse; M Lefevre; S Jourdain; G Lelay; L Daniel; M Virmaux; I Le Du; D Tande; A Renault; B Lejeune
Journal:  J Hosp Infect       Date:  2010-12-30       Impact factor: 3.926

2.  Counting the cost of an outbreak of carbapenemase-producing Enterobacteriaceae: an economic evaluation from a hospital perspective.

Authors:  J A Otter; P Burgess; F Davies; S Mookerjee; J Singleton; M Gilchrist; D Parsons; E T Brannigan; J Robotham; A H Holmes
Journal:  Clin Microbiol Infect       Date:  2016-10-13       Impact factor: 8.067

Review 3.  The changing epidemiology of Clostridium difficile infections.

Authors:  J Freeman; M P Bauer; S D Baines; J Corver; W N Fawley; B Goorhuis; E J Kuijper; M H Wilcox
Journal:  Clin Microbiol Rev       Date:  2010-07       Impact factor: 26.132

4.  The Cost of Responding to an Acinetobacter Outbreak in Critically Ill Surgical Patients.

Authors:  Yushan Jiang; Stephen Resch; Xiaoxia Liu; Selwyn O Rogers; Reza Askari; Michael Klompas; Sudha P Jayaraman
Journal:  Surg Infect (Larchmt)       Date:  2015-09-10       Impact factor: 2.150

5.  Direct costs associated with a nosocomial outbreak of Salmonella infection: an ounce of prevention is worth a pound of cure.

Authors:  N M Spearing; A Jensen; B J McCall; A S Neill; J G McCormack
Journal:  Am J Infect Control       Date:  2000-02       Impact factor: 2.918

6.  Attributable costs and length of stay of an extended-spectrum beta-lactamase-producing Klebsiella pneumoniae outbreak in a neonatal intensive care unit.

Authors:  Patricia W Stone; Archana Gupta; Maureen Loughrey; Phyllis Della-Latta; Jeannie Cimiotti; Elaine Larson; David Rubenstein; Lisa Saiman
Journal:  Infect Control Hosp Epidemiol       Date:  2003-08       Impact factor: 3.254

7.  Hospital economic impact of an outbreak of Pseudomonas aeruginosa infections.

Authors:  R Bou; L Lorente; A Aguilar; J Perpiñán; P Ramos; M Peris; D Gonzalez
Journal:  J Hosp Infect       Date:  2008-09-16       Impact factor: 3.926

8.  Raising standards while watching the bottom line: making a business case for infection control.

Authors:  Eli N Perencevich; Patricia W Stone; Sharon B Wright; Yehuda Carmeli; David N Fisman; Sara E Cosgrove
Journal:  Infect Control Hosp Epidemiol       Date:  2007-10       Impact factor: 3.254

9.  Cost-Analysis of Seven Nosocomial Outbreaks in an Academic Hospital.

Authors:  Jan-Willem H Dik; Ariane G Dinkelacker; Pepijn Vemer; Jerome R Lo-Ten-Foe; Mariëtte Lokate; Bhanu Sinha; Alex W Friedrich; Maarten J Postma
Journal:  PLoS One       Date:  2016-02-10       Impact factor: 3.240

10.  Effects of control interventions on Clostridium difficile infection in England: an observational study.

Authors:  Kate E Dingle; Xavier Didelot; T Phuong Quan; David W Eyre; Nicole Stoesser; Tanya Golubchik; Rosalind M Harding; Daniel J Wilson; David Griffiths; Alison Vaughan; John M Finney; David H Wyllie; Sarah J Oakley; Warren N Fawley; Jane Freeman; Kirsti Morris; Jessica Martin; Philip Howard; Sherwood Gorbach; Ellie J C Goldstein; Diane M Citron; Susan Hopkins; Russell Hope; Alan P Johnson; Mark H Wilcox; Timothy E A Peto; A Sarah Walker; Derrick W Crook
Journal:  Lancet Infect Dis       Date:  2017-01-25       Impact factor: 71.421

  10 in total
  1 in total

1.  Clostridium difficile infection investigation and multidisciplinary team root cause analysis.

Authors:  Susan Dawson; Hilary Munube
Journal:  J Infect Prev       Date:  2018-03-23
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.